A role of CREB in BRCA1 constitutive promoter activity and aromatase basal expression

Sagar Ghosh, Yunzhe Lu, Yanfen Hu

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Aromatase is the rate-limiting enzyme in estrogen biosynthesis and a key target in breast cancer treatment. Its ovary-specific promoter, PII, is induced in response to protein kinase A (PKA) activation. It has been proposed that breast cancer susceptibility gene 1, BRCA1, is involved in negative regulation of aromatase PII activity. Surprisingly, inhibition of PKA pathway by inhibitor H89 elevates basal aromatase expression while abolishes cAMP-mediated aromatase induction in an ovarian granulosa cell line, KGN. In this report, we decipher the mechanism by which the PKA pathway negatively regulates aromatase basal expression. We show that PKA pathway plays a positive role in the expression of BRCA1. H89 effectively reduces endogenous BRCA1 mRNA levels as well as reporter gene expression from a BRCA1 promoter. Mutation of a cAMP-responsive element (CRE) in the BRCA1 promoter reduces BRCA1 expression. Chromatin immunoprecipitation (ChIP) shows that CRE-binding protein, CREB, binds to the BRCA1 promoter. Furthermore, knockdown of CREB in KGN cells leads to decreased BRCA1 level as well as elevated basal aromatase mRNA expression. These data demonstrate that both the CRE site in the BRCA1 promoter and CREB are required for BRCA1 constitutive expression. Our study suggests that PKA pathway exerts its negative impact on basal aromatase expression indirectly by contributing to the constitutive expression of BRCA1.

Original languageEnglish (US)
Pages (from-to)260-265
Number of pages6
JournalInternational Journal of Biomedical Science
Volume4
Issue number4
StatePublished - Dec 15 2008

Fingerprint

Aromatase
Cyclic AMP-Dependent Protein Kinases
CREB-Binding Protein
Breast Neoplasms
Messenger RNA
Oncology
Granulosa Cells
Chromatin Immunoprecipitation
Neoplasm Genes
Biosynthesis
Reporter Genes
Gene expression
Chromatin
Ovary
Estrogens
Genes
Chemical activation
Cells
Gene Expression
Cell Line

Keywords

  • Aromatase
  • BRCA1
  • CREB

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

A role of CREB in BRCA1 constitutive promoter activity and aromatase basal expression. / Ghosh, Sagar; Lu, Yunzhe; Hu, Yanfen.

In: International Journal of Biomedical Science, Vol. 4, No. 4, 15.12.2008, p. 260-265.

Research output: Contribution to journalArticle

@article{5bb9f0bcde49408692dab1901f67b89a,
title = "A role of CREB in BRCA1 constitutive promoter activity and aromatase basal expression",
abstract = "Aromatase is the rate-limiting enzyme in estrogen biosynthesis and a key target in breast cancer treatment. Its ovary-specific promoter, PII, is induced in response to protein kinase A (PKA) activation. It has been proposed that breast cancer susceptibility gene 1, BRCA1, is involved in negative regulation of aromatase PII activity. Surprisingly, inhibition of PKA pathway by inhibitor H89 elevates basal aromatase expression while abolishes cAMP-mediated aromatase induction in an ovarian granulosa cell line, KGN. In this report, we decipher the mechanism by which the PKA pathway negatively regulates aromatase basal expression. We show that PKA pathway plays a positive role in the expression of BRCA1. H89 effectively reduces endogenous BRCA1 mRNA levels as well as reporter gene expression from a BRCA1 promoter. Mutation of a cAMP-responsive element (CRE) in the BRCA1 promoter reduces BRCA1 expression. Chromatin immunoprecipitation (ChIP) shows that CRE-binding protein, CREB, binds to the BRCA1 promoter. Furthermore, knockdown of CREB in KGN cells leads to decreased BRCA1 level as well as elevated basal aromatase mRNA expression. These data demonstrate that both the CRE site in the BRCA1 promoter and CREB are required for BRCA1 constitutive expression. Our study suggests that PKA pathway exerts its negative impact on basal aromatase expression indirectly by contributing to the constitutive expression of BRCA1.",
keywords = "Aromatase, BRCA1, CREB",
author = "Sagar Ghosh and Yunzhe Lu and Yanfen Hu",
year = "2008",
month = "12",
day = "15",
language = "English (US)",
volume = "4",
pages = "260--265",
journal = "International Journal of Biomedical Science",
issn = "1550-9702",
publisher = "Master Publishing Group",
number = "4",

}

TY - JOUR

T1 - A role of CREB in BRCA1 constitutive promoter activity and aromatase basal expression

AU - Ghosh, Sagar

AU - Lu, Yunzhe

AU - Hu, Yanfen

PY - 2008/12/15

Y1 - 2008/12/15

N2 - Aromatase is the rate-limiting enzyme in estrogen biosynthesis and a key target in breast cancer treatment. Its ovary-specific promoter, PII, is induced in response to protein kinase A (PKA) activation. It has been proposed that breast cancer susceptibility gene 1, BRCA1, is involved in negative regulation of aromatase PII activity. Surprisingly, inhibition of PKA pathway by inhibitor H89 elevates basal aromatase expression while abolishes cAMP-mediated aromatase induction in an ovarian granulosa cell line, KGN. In this report, we decipher the mechanism by which the PKA pathway negatively regulates aromatase basal expression. We show that PKA pathway plays a positive role in the expression of BRCA1. H89 effectively reduces endogenous BRCA1 mRNA levels as well as reporter gene expression from a BRCA1 promoter. Mutation of a cAMP-responsive element (CRE) in the BRCA1 promoter reduces BRCA1 expression. Chromatin immunoprecipitation (ChIP) shows that CRE-binding protein, CREB, binds to the BRCA1 promoter. Furthermore, knockdown of CREB in KGN cells leads to decreased BRCA1 level as well as elevated basal aromatase mRNA expression. These data demonstrate that both the CRE site in the BRCA1 promoter and CREB are required for BRCA1 constitutive expression. Our study suggests that PKA pathway exerts its negative impact on basal aromatase expression indirectly by contributing to the constitutive expression of BRCA1.

AB - Aromatase is the rate-limiting enzyme in estrogen biosynthesis and a key target in breast cancer treatment. Its ovary-specific promoter, PII, is induced in response to protein kinase A (PKA) activation. It has been proposed that breast cancer susceptibility gene 1, BRCA1, is involved in negative regulation of aromatase PII activity. Surprisingly, inhibition of PKA pathway by inhibitor H89 elevates basal aromatase expression while abolishes cAMP-mediated aromatase induction in an ovarian granulosa cell line, KGN. In this report, we decipher the mechanism by which the PKA pathway negatively regulates aromatase basal expression. We show that PKA pathway plays a positive role in the expression of BRCA1. H89 effectively reduces endogenous BRCA1 mRNA levels as well as reporter gene expression from a BRCA1 promoter. Mutation of a cAMP-responsive element (CRE) in the BRCA1 promoter reduces BRCA1 expression. Chromatin immunoprecipitation (ChIP) shows that CRE-binding protein, CREB, binds to the BRCA1 promoter. Furthermore, knockdown of CREB in KGN cells leads to decreased BRCA1 level as well as elevated basal aromatase mRNA expression. These data demonstrate that both the CRE site in the BRCA1 promoter and CREB are required for BRCA1 constitutive expression. Our study suggests that PKA pathway exerts its negative impact on basal aromatase expression indirectly by contributing to the constitutive expression of BRCA1.

KW - Aromatase

KW - BRCA1

KW - CREB

UR - http://www.scopus.com/inward/record.url?scp=77953378222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953378222&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 260

EP - 265

JO - International Journal of Biomedical Science

JF - International Journal of Biomedical Science

SN - 1550-9702

IS - 4

ER -